AVEO Stock: Up on Collaboration With BMY

AVEO Oncology AVEO Stock News

AVEO Oncology (NASDAQ: AVEO) recently announced the FDA approval of FOTIVDA. So, the stock has been on the radar of several investors are commercialization will commence in the next couple of months.  Now, the company is looking to take the treatment another step forward, with an announcement this morning that it has entered into a … Read more

Bristol Myers Squibb (BMY) Stock: Gaining On Strong Earnings And Clinical Results

Bristol-Myers Squibb Co (NYSE: BMY) is off to an incredibly strong start in the pre-market hours today, and for good reason. The company not only released its fourth quarter and full year 2017 earnings, but news with regard to a key clinical trial was also released, leading to excitement among investors. Today, we’ll talk about the … Read more

Bristol-Myers Squibb (BMY) Stock: Spiking On Rumor Of PFE Takeover

Bristol-Myers Squibb Co (NYSE: BMY) is is experiencing a relatively strong spike in the market at the moment, and for good reason. There are rumors surfacing that the company will soon be taken over. Of course, these rumors are leading to excitement among investors, sending the stock upward. Of course, our partners at Trade Ideas … Read more

Bristol-Myers Squibb (BMY) Stock Taking A Dive On Failed Study

Bristol-Myers Squibb Co (NYSE: BMY) Bristol-Myers Squibb is having a tremendously rough day in the market today, and for good reason. The company reported that an immune-based therapy it has been working on for the treatment of lung cancer has failed for the second time. Today, we’ll talk about the news, what we’re seeing from the … Read more